ApicHope Pharmaceutical Co., Ltd

XSEC:300723 Stock Report

Market Cap: CN¥8.4b

ApicHope Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Hanxiong Li

Chief executive officer

CN¥653.6k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership16.1%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Hanxiong Li (50 yo)

no data

Tenure

CN¥653,600

Compensation

Mr. Hanxiong Li serves as Chairman of the Board of Directors and General Manager at ApicHope Pharmaceutical Co., Ltd (formerly Yipinhong Pharmaceutical Co., Ltd). He is Director of Arthrosi Therapeutics, I...

Board Members

NamePositionTenureCompensationOwnership
Hanxiong Li
Chairman of the Board of Directors & GMno dataCN¥653.60k16.06%
CN¥ 1.4b
Dongling Yang
Deputy GM & Non-Independent Directorno dataCN¥1.32mno data
Kejian Zhang
Independent Directorless than a yearno datano data
Zhihong Yan
Non-Employee Supervisorless than a yearCN¥1.01mno data
Handong Li
Non-Independent Directorno dataCN¥453.60k3.04%
CN¥ 255.9m
Liangwen Huang
Chairman of the Supervisory Boardno datano datano data
Ruiyu Ke
Supervisor3yrsno datano data
Yingying Zhang
Non-Employee Supervisorno datano datano data
Jianhong Tao
Independent Director3yrsCN¥120.00kno data
Deming Yang
Independent Director3yrsCN¥120.00k0.0044%
CN¥ 374.9k
Qiwu Xie
Non-Employee Supervisorless than a yearno datano data
Xianhua Hu
Independent Directorless than a yearno datano data

0.4yrs

Average Tenure

50yo

Average Age

Experienced Board: 300723's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 00:42
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ApicHope Pharmaceutical Co., Ltd is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kehan MengHaitong International Research Limited
Wen DaiHuatai Research
Jiaxi XuIndustrial Securities Co. Ltd.